FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938816076> ?p ?o ?g. }

• W2938816076 endingPage "185" @default.
• W2938816076 startingPage "176" @default.
• W2938816076 abstract "Eph receptor tyrosine kinases have a wide range of biological functions and have gradually been recognized increasingly as key regulators of inflammation and injury diseases. Although previous studies suggested that EphA2 receptor may be involved in the regulation of inflammation and vascular permeability in injured lung, the detailed effects of EphA2 on LPS-induced acute lung injury (ALI) are still inadequate and the underlying mechanism remains poorly understood. In this study, we detected the effects of EphA2 antagonism on inflammation, pulmonary vascular permeability and oxidative stress in LPS-induced ALI and investigate the potential mechanism. Our results showed that EphA2 antagonism markedly inhibited the cytokines release and inflammatory cells infiltration in BALF, prevented the LPS-induced elevations of MPO activity and MDA level in lung tissues. Our study also found that EphA2 antagonism significantly decreased the wet/dry ratios, reduced the Evans blue albumin extravasation in lung tissues and obviously alleviated the LPS-induced increment of pulmonary vascular permeability. Mechanistically, EphA2 antagonism significantly increased the activation of Nrf2 along with its target antioxidant enzyme HO-1 and inhibited the expressions of TLR4/MyD88 in lung tissues and A549 alveolar epithelial cells. Furthermore, EphA2 antagonism dramatically inhibited the LPS-evoked activations of RhoA/ROCK in lung tissues. In conclusion, our data indicate that EphA2 receptor plays an essential role in LPS-induced ALI and EphA2 antagonism has protective effects against LPS-induced ALI via Nrf2/HO-1, TLR4/MyD88 and RhoA/ROCK pathways. These results suggest that antagonism of EphA2 may be an effective therapeutic strategy for the treatment of ALI." @default.
• W2938816076 created "2019-04-25" @default.
• W2938816076 creator A5001962625 @default.
• W2938816076 creator A5005481695 @default.
• W2938816076 creator A5013248335 @default.
• W2938816076 creator A5039104880 @default.
• W2938816076 creator A5058723247 @default.
• W2938816076 creator A5077107791 @default.
• W2938816076 date "2019-07-01" @default.
• W2938816076 modified "2023-10-16" @default.
• W2938816076 title "EphA2 antagonism alleviates LPS-induced acute lung injury via Nrf2/HO-1, TLR4/MyD88 and RhoA/ROCK pathways" @default.
• W2938816076 cites W1655204455 @default.
• W2938816076 cites W1951409959 @default.
• W2938816076 cites W1990488806 @default.
• W2938816076 cites W1994137567 @default.
• W2938816076 cites W1995827114 @default.
• W2938816076 cites W2003423901 @default.
• W2938816076 cites W2038385234 @default.
• W2938816076 cites W2045188253 @default.
• W2938816076 cites W2064121269 @default.
• W2938816076 cites W2077923797 @default.
• W2938816076 cites W2085206681 @default.
• W2938816076 cites W2085754834 @default.
• W2938816076 cites W2096043623 @default.
• W2938816076 cites W2116583438 @default.
• W2938816076 cites W2117942720 @default.
• W2938816076 cites W2128916257 @default.
• W2938816076 cites W2156284838 @default.
• W2938816076 cites W2159763561 @default.
• W2938816076 cites W2171365654 @default.
• W2938816076 cites W2272062950 @default.
• W2938816076 cites W2330906305 @default.
• W2938816076 cites W2335742033 @default.
• W2938816076 cites W2401517356 @default.
• W2938816076 cites W2416067870 @default.
• W2938816076 cites W2513513389 @default.
• W2938816076 cites W2514943144 @default.
• W2938816076 cites W2522148900 @default.
• W2938816076 cites W2556899316 @default.
• W2938816076 cites W2608651856 @default.
• W2938816076 cites W2754374515 @default.
• W2938816076 cites W2754664951 @default.
• W2938816076 cites W2765800759 @default.
• W2938816076 cites W2779487985 @default.
• W2938816076 cites W4205247160 @default.
• W2938816076 cites W4233020934 @default.
• W2938816076 doi "https://doi.org/10.1016/j.intimp.2019.04.008" @default.
• W2938816076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30986645" @default.
• W2938816076 hasPublicationYear "2019" @default.
• W2938816076 type Work @default.
• W2938816076 sameAs 2938816076 @default.
• W2938816076 citedByCount "20" @default.
• W2938816076 countsByYear W29388160762019 @default.
• W2938816076 countsByYear W29388160762020 @default.
• W2938816076 countsByYear W29388160762021 @default.
• W2938816076 countsByYear W29388160762022 @default.
• W2938816076 countsByYear W29388160762023 @default.
• W2938816076 crossrefType "journal-article" @default.
• W2938816076 hasAuthorship W2938816076A5001962625 @default.
• W2938816076 hasAuthorship W2938816076A5005481695 @default.
• W2938816076 hasAuthorship W2938816076A5013248335 @default.
• W2938816076 hasAuthorship W2938816076A5039104880 @default.
• W2938816076 hasAuthorship W2938816076A5058723247 @default.
• W2938816076 hasAuthorship W2938816076A5077107791 @default.
• W2938816076 hasConcept C101544691 @default.
• W2938816076 hasConcept C113045295 @default.
• W2938816076 hasConcept C126322002 @default.
• W2938816076 hasConcept C150582083 @default.
• W2938816076 hasConcept C164027704 @default.
• W2938816076 hasConcept C170493617 @default.
• W2938816076 hasConcept C185592680 @default.
• W2938816076 hasConcept C203014093 @default.
• W2938816076 hasConcept C2776070231 @default.
• W2938816076 hasConcept C2776914184 @default.
• W2938816076 hasConcept C2777093181 @default.
• W2938816076 hasConcept C2777383412 @default.
• W2938816076 hasConcept C2777649898 @default.
• W2938816076 hasConcept C2779540182 @default.
• W2938816076 hasConcept C55493867 @default.
• W2938816076 hasConcept C62478195 @default.
• W2938816076 hasConcept C71924100 @default.
• W2938816076 hasConcept C98274493 @default.
• W2938816076 hasConceptScore W2938816076C101544691 @default.
• W2938816076 hasConceptScore W2938816076C113045295 @default.
• W2938816076 hasConceptScore W2938816076C126322002 @default.
• W2938816076 hasConceptScore W2938816076C150582083 @default.
• W2938816076 hasConceptScore W2938816076C164027704 @default.
• W2938816076 hasConceptScore W2938816076C170493617 @default.
• W2938816076 hasConceptScore W2938816076C185592680 @default.
• W2938816076 hasConceptScore W2938816076C203014093 @default.
• W2938816076 hasConceptScore W2938816076C2776070231 @default.
• W2938816076 hasConceptScore W2938816076C2776914184 @default.
• W2938816076 hasConceptScore W2938816076C2777093181 @default.
• W2938816076 hasConceptScore W2938816076C2777383412 @default.
• W2938816076 hasConceptScore W2938816076C2777649898 @default.
• W2938816076 hasConceptScore W2938816076C2779540182 @default.
• W2938816076 hasConceptScore W2938816076C55493867 @default.
• W2938816076 hasConceptScore W2938816076C62478195 @default.

• next